Skip to main content

Advertisement

Log in

Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Racial and ethnic minority patients continue to die disproportionately from breast cancer compared with their white counterparts, even after adjusting for insurance status and income. No studies have examined whether surveillance mammography reduces racial disparities in survival among elderly breast cancer survivors following active treatment for breast cancer. This study included 28,117 cases diagnosed with primary breast cancer at age 66 years and over, identified from SEER data during 1992–2005. Kaplan–Meier methods and Cox regression models were used for survival analysis. A higher proportion of whites received surveillance mammograms during the surveillance period compared with nonwhites: 71.7 % of African-Americans, 72.5 % of Hispanics, and 69.3 % of Asians had mammograms compared with 74.9 % of whites. In propensity-score-adjusted analysis, women who had a mammogram within 2 years were less likely (hazard ratio 0.84; 95 % CI 0.78–0.82) to die from any cause compared with women who did not have any mammograms during this time period. The hazard ratio of cancer-specific mortality elevated for Hispanics compared with whites (hazard ratio 1.5; 95 % CI 0.6–3.2) and was reduced after adjusting for surveillance mammography (hazard ratio 1.4; 95 % CI 0.5–2.9). Similar pattern in the reduction in disease-specific hazard ratio was observed for blacks: After controlling for patient and tumor characteristics, hazard ratio was elevated but not significantly different from that in whites (hazard ratio 2.0; 95 % CI 0.9–3.7), and hazard ratio adjusting for surveillance mammography further reduced the point estimate (hazard ratio 1.5; 95 % CI 0.7–2.8). Asian and Pacific Islanders and Hispanics appeared to have lower risks of all-cause mortality compared with whites after controlling for patient and tumor characteristics and surveillance mammogram received. Our findings indicates that while surveillance mammograms and physician visits may play a contributory role in achieving equal outcomes for breast cancer-specific mortality for women with breast cancer, searching for other factors that might help achieve national goals to eliminate racial disparities in healthcare, and outcomes is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mead H, Cartwright-Smith L, Jones K, et al. Racial and Ethnic Disparities in US Healthcare: A Chartbook. New York: The Commonwealth Fund; 2008.

    Google Scholar 

  2. Smith TJ, Davidson NE, Schapira DV, et al. American society of clinical oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080–2.

    CAS  PubMed  Google Scholar 

  3. National Comprehensive Cancer Network: NCCN Practice Guidelines in Oncology, v. 1.2005. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.

  4. Clark A, Fong C, Romans M. Health disparities among U.S. women of color: an overview. Washington, DC: The Jacobs Institute of Women’s Health; 2002.

    Google Scholar 

  5. Schootman M, Jeffe DB, Lian M, Aft R, Gillanders WE. Surveillance mammography and the risk of death among elderly breast cancer patients. Breast Cancer Res Treat. 2008;111:489–96.

    Article  PubMed  Google Scholar 

  6. Shapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–9.

    Article  Google Scholar 

  7. Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care. 2001;39:945–55.

    Article  CAS  PubMed  Google Scholar 

  8. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography. Among breast cancer survivors. J Clin Oncol. 2006;24:85–94.

    Article  PubMed  Google Scholar 

  9. Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23(2):158–63.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Fouad M, Wynn T, Martin M, Partridge E. Patient navigation pilot project: results from the community health advisors in action program (CHAAP). Ethn Dis. 2010;20(2):155–61.

    PubMed  Google Scholar 

  11. Butler Nattinger A, Schapira MM, Warren JL, Earle CC. Methodological issues in the use of administrative claims data to study surveillance after cancer treatment. Med Care. 2002;40(8 Suppl):IV-69–74.

    Google Scholar 

  12. Blustein J. Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med. 1995;332:1138–43.

    Article  CAS  PubMed  Google Scholar 

  13. May DS, Trontell AE. Mammography use by elderly women: a methodological comparison of two national data sources. Ann Epidemiol. 1998;8(7):439–44.

    Article  CAS  PubMed  Google Scholar 

  14. Randolph WM, Mahnken JD, Goodwin JS, Freeman JL. Using medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. Health Serv Res. 2002;37(6):1643–57.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Randolph WM, Goodwin JS, Mahnken JD, Freeman JL. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med. 2002;137(10):783–90.

    Article  PubMed  Google Scholar 

  16. Cooper GS, Schultz L, Simpkins J, Lafata JE. The utility of administrative data for measuring adherence to cancer surveillance care guidelines. Med Care. 2007;45(1):66–72.

    Article  PubMed  Google Scholar 

  17. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV-3–18.

    Google Scholar 

  18. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258–67.

    Article  CAS  PubMed  Google Scholar 

  19. National Cancer Institute. SEER-Medicare: Calculation of Comorbidity Weights. Available at http://healthservices.cancer.gov/seermedicare/ program/comorbidity.html).

  20. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.

    Article  CAS  PubMed  Google Scholar 

  22. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER medicare data to identify chemotherapy use. Med Care. 2002;40(8 Suppl):IV-55–61.

    Google Scholar 

  23. Du X, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer. 2001;92:730–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Culler SD, Parchman ML, Przybylski M. Factors related to potentially preventable hospitalizations among the elderly. Med Care. 1998;36(6):804–17.

    Article  CAS  PubMed  Google Scholar 

  25. Parchman ML, Culler SD. Preventable hospitalizations in primary care shortage area. An analysis of vulnerable Medicare beneficiaries. Arch Fam Med. 1999;8:487–91.

    Article  CAS  PubMed  Google Scholar 

  26. Weissman JS, Gatsonis C, Epstein AM. Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland. JAMA. 1992;268(17):2388–94.

    Article  CAS  PubMed  Google Scholar 

  27. Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21(8):1447–51.

    Article  PubMed  Google Scholar 

  28. Rao S, Kubisiak J, Gilden D. Cost of illness associated with metastatic breast cancer. Breast Cancer Res Treat. 2004;83(1):25–32.

    Article  CAS  PubMed  Google Scholar 

  29. Rosenbaum P. Observational studies. 2nd ed. New York: Springer; 2002.

    Book  Google Scholar 

  30. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757–63.

    Article  CAS  PubMed  Google Scholar 

  31. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–56.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf. 2004;13:841–53.

    Article  PubMed  Google Scholar 

  33. Robert O. Morgan, Virnig BA, Petersen LA et al. Medicare + Choice and Minority Elderly Final report for R01AG019284-03, May 31, 2009.

  34. Paszat L, Sutradhar R, Grunfeld E, Gainford C, Benk V, Bondy S, Coyle D, Holloway C, Sawka C, Shumak R, Vallis K, van Walraven C. Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series. Breast Cancer Res Treat. 2009;114(1):169–78.

    Article  PubMed  Google Scholar 

  35. Brown ML, Houn F, Sickles EA, Kessler LG. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol. 1995;165(6):1373–7.

    Article  CAS  PubMed  Google Scholar 

  36. Lairson DR, Chan W, Chang YC, Del Junco DJ, Vernon SW. Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States. Eval Program Plan. 2011;34(2):97–104.

    Article  Google Scholar 

  37. Fowler T, Steakley C, Garcia AR, et al. Reducing disparities in the burden of cancer: the role of patient navigators. PLoS Med. 2006;3:e193.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011;117(15 suppl):3539–42.

    PubMed  Google Scholar 

  39. Raj A, Ko N, Battaglia TA, Chabner BA, Moy B. Patient navigation for underserved patients diagnosed with breast cancer. Oncologist. 2012;17:1027–31.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge the efforts of the National Cancer Institute; Center for Medicare and Medicaid Services; Information Management Services, Inc.; and the Surveillance, Epidemiology, and End Results Program tumor registries in the creation of this database. The interpretation and reporting of these data are the sole responsibilities of the authors. We thank “A Transdisciplinary Training Program for Public Health Researcher and Practitioners wanting to Impact Breast Cancer Disparities” KG090010 Susan G. Komen Breast Cancer Foundation for financial support for a pre-doctoral student (ZN). This study was also supported in part by a grant from the Agency for Healthcare Research and Quality (R01-HS018956) and in part by a grant from the Cancer Prevention and Research Institute of Texas (RP101207).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z. Z. Nurgalieva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nurgalieva, Z.Z., Franzini, L., Morgan, R. et al. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival. Med Oncol 30, 691 (2013). https://doi.org/10.1007/s12032-013-0691-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0691-8

Keywords

Navigation